The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation.
Demirer
T
T
Ayli
M
M
Dagli
M
M
Fen
T
T
Haznedar
R
R
Ustael
N
N
Ustun
T
T
Oymak
A
A
Ozdel
O
O
Muftuoglu
O
O
D000293:Adolescent; D000328:Adult; D004232:Diuretics / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D011188:Potassium / Q000008:administration & dosage* / Q000097:blood; D013148:Spironolactone / Q000008:administration & dosage / Q000494:pharmacology*; D014182:Transplantation, Autologous
D004232:Diuretics; D013148:Spironolactone; D011188:Potassium